Indication
Movement Disorders
4 clinical trials
6 products
Product
Altropane (123I)Clinical trial
An Open-label Multicenter Phase 2 Dose-evaluation Study of Altropane (123I) Injection for Striatal Dopamine Transporter Visualization Using SPECT Brain ImagingStatus: Recruiting, Estimated PCD: 2024-03-29
Product
AltropaneClinical trial
A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo- Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa- Induced Dyskinesia in Subjects With Parkinson's DiseaseStatus: , Estimated PCD: 2023-12-30
Product
MidazolamProduct
KetamineClinical trial
A Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of 40mg/Day KW-6002 (Istradefylline) as Monotherapy in Subjects With Parkinson's DiseaseStatus: Completed, Estimated PCD: 2006-07-01
Product
IstradefyllineClinical trial
Role and Mechanism of Bifidobacterium Triple Viable Capsules in Improving Motor Symptoms in Patients With Mild to Moderate Parkinson's Disease: a Multicenter Randomized Clinical StudyStatus: Recruiting, Estimated PCD: 2023-10-01